(1)
Foley, R.; Owen, C.; Tabchi, S.; Razavi, G. Panel Discussion: Treatment Options for relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) Patients. Can Hematol Today 2022, 1.